Crinetics Pharmaceuticals, Inc. (CRNX)

Latest Insider Confidence Score

2026Q1

48.0
Bearish

Company insider confidence (by quarter)

2018Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Perceptive Advisors Llc 10% Owner 5,321,032 Apr 18, 2022
Perceptive Life Sciences Master Fund Ltd 10% Owner 5,321,032 Apr 18, 2022
Edelman Joseph 10% Owner 5,321,032 Apr 18, 2022
Struthers Richard Scott CEO 1,192,222 Sep 30, 2025
Vivo Capital VIII, LLC 10% Owner 298,625 Apr 17, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 4, 2026 Okey Stephanie Director Sell 21.3 -3,000 -18.40% ✓ $119K
Mar 3, 2026 Mar 4, 2026 Schilke Tobin CFO Sell 28.8 -6,713 -7.91% ✓ $266.3K
Feb 23, 2026 Feb 25, 2026 Struthers Richard Scott CEO Neutral 82.5 +62,000 4.62% ✗ -
Feb 23, 2026 Feb 25, 2026 Schilke Tobin CFO Neutral 90.0 +32,000 60.57% ✗ -
Feb 23, 2026 Feb 25, 2026 Knight Jeff E. COO Neutral 90.0 +34,000 38.67% ✗ -
Feb 23, 2026 Feb 25, 2026 Betz Stephen F. Chief Scientific Officer Neutral 90.0 +30,000 25.49% ✗ -
Feb 23, 2026 Feb 25, 2026 Kalofonos Isabel Chief Commercial Officer Neutral 90.0 +34,000 4076.74% ✗ -
Jan 5, 2026 Jan 7, 2026 Kalofonos Isabel Chief Commercial Officer Sell 11.3 -2,500 -74.99% ✓ $137.5K
Dec 26, 2025 Dec 29, 2025 Betz Stephen F. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 18, 2025 Dec 18, 2025 Struthers Richard Scott CEO Neutral 52.5 - 0.00% ✗ -
Dec 1, 2025 Dec 3, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 32.5 -5,000 -6.96% ✓ $225.1K
Nov 3, 2025 Nov 5, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 32.5 -5,000 -7.02% ✓ $213.3K
Oct 1, 2025 Oct 3, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 32.5 -5,000 -7.02% ✓ $209.1K
Sep 26, 2025 Sep 30, 2025 Struthers Richard Scott CEO Sell 48.8 -4,000 -0.31% ✓ $180K
Sep 26, 2025 Sep 30, 2025 Fust Matthew K Director Sell 7.5 -16,000 -41.20% ✓ $716K
Sep 2, 2025 Sep 4, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 37.5 -5,000 -4.94% ✓ $160.5K
Aug 22, 2025 Aug 26, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -30,000 -31.16% ✓ $912.9K
Aug 20, 2025 Aug 21, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 28.8 -6,492 -8.92% ✓ $189.4K
Jun 12, 2025 Jun 16, 2025 Betz Stephen F. Chief Scientific Officer Sell 5.0 -97,483 -49.43% ✓ $3.1M
Jun 11, 2025 Jun 13, 2025 Okey Stephanie Director Neutral 90.0 +6,900 73.40% ✗ -
Jun 11, 2025 Jun 13, 2025 Deardorf Caren Director Neutral 90.0 +6,900 73.40% ✗ -
Jun 11, 2025 Jun 13, 2025 Vivaldi Coelho Rogerio Director Neutral 90.0 +6,900 47.92% ✗ -
Jun 11, 2025 Jun 13, 2025 Fust Matthew K Director Neutral 90.0 +6,900 31.46% ✗ -
Jun 11, 2025 Jun 13, 2025 Bedrosian Camille L Director Neutral 90.0 +6,900 73.40% ✗ -
Jun 11, 2025 Jun 13, 2025 Nichols Weston Director Neutral 90.0 +6,900 73.40% ✗ -
Jun 11, 2025 Jun 13, 2025 WIERENGA WENDALL Director Neutral 85.0 +6,900 6.32% ✗ -
May 14, 2025 May 16, 2025 Struthers Richard Scott CEO Neutral 52.5 - 0.00% ✗ -
Apr 2, 2025 Apr 4, 2025 Struthers Richard Scott CEO Neutral 52.5 - 0.00% ✗ -
Mar 19, 2025 Mar 21, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 37.5 -2,515 -3.36% ✓ $86K
Mar 19, 2025 Mar 21, 2025 Knight Jeff E. COO Sell 28.8 -7,162 -7.57% ✓ $245K
Mar 19, 2025 Mar 21, 2025 Betz Stephen F. Chief Scientific Officer Sell 32.5 -5,770 -5.05% ✓ $197.4K
Mar 19, 2025 Mar 21, 2025 Struthers Richard Scott CEO Sell 42.5 -17,338 -1.40% ✓ $593K
Mar 10, 2025 Mar 11, 2025 Schilke Tobin CFO Neutral 90.0 +52,000 100.00% ✗ -
Mar 5, 2025 Schilke Tobin CFO Neutral 52.5 - 0.00% ✗ -
Feb 20, 2025 Feb 24, 2025 Struthers Richard Scott CEO Neutral 85.0 +89,000 7.74% ✗ -
Feb 20, 2025 Feb 24, 2025 Knight Jeff E. COO Neutral 90.0 +43,000 83.25% ✗ -
Feb 20, 2025 Feb 24, 2025 Pizzuti Dana Chief Med and Dev Officer Neutral 90.0 +43,000 135.44% ✗ -
Feb 20, 2025 Feb 24, 2025 Betz Stephen F. Chief Scientific Officer Neutral 90.0 +43,000 60.26% ✗ -
Feb 3, 2025 Feb 5, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 25.0 -5,000 -13.61% ✓ $195.4K
Nov 20, 2024 Jan 29, 2025 Betz Stephen F. Chief Scientific Officer Buy 67.5 +451 0.64% ✗ $6.8K
Nov 20, 2024 Jan 29, 2025 Wilson Marc CFO Buy 60.0 +473 0.43% ✗ $7.1K
Jan 10, 2025 Jan 13, 2025 Kalofonos Isabel Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2025 Jan 7, 2025 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -15,000 -33.90% ✓ $781.4K
Dec 30, 2024 Kalofonos Isabel Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2024 Dec 18, 2024 Betz Stephen F. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 2, 2024 Dec 4, 2024 Struthers Richard Scott CEO Sell 45.0 -10,000 -0.86% ✓ $575.7K
Nov 22, 2024 Nov 26, 2024 Knight Jeff E. COO Sell 51.3 -501 -0.96% ✓ $28.3K
Oct 3, 2024 Oct 7, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -14,375 -33.52% ✓ $785.3K
Sep 26, 2024 Sep 30, 2024 Wilson Marc CFO Sell 15.0 -25,000 -18.37% ✓ $1.3M
Sep 10, 2024 Sep 12, 2024 Betz Stephen F. Chief Scientific Officer Sell 45.0 -1,035 -1.49% ✓ $53.3K
Aug 26, 2024 Aug 28, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -4.13% ✓ $159.6K
Aug 12, 2024 Aug 14, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.97% ✓ $143K
Jul 25, 2024 Jul 26, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.82% ✓ $160.3K
Jul 25, 2024 Jul 26, 2024 Wilson Marc CFO Sell 20.0 -19,056 -14.64% ✓ $1M
Jul 15, 2024 Jul 17, 2024 Knight Jeff E. COO Sell 5.0 -27,000 -34.33% ✓ $1.5M
Jul 15, 2024 Jul 17, 2024 Wilson Marc CFO Sell 15.0 -25,000 -18.37% ✓ $1.4M
Jul 10, 2024 Jul 12, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.68% ✓ $145.7K
Jul 5, 2024 Jul 9, 2024 Hassard James Chief Commercial Officer Sell 7.5 -15,000 -33.89% ✓ $661.2K
Jul 3, 2024 Jul 5, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -14,375 -33.52% ✓ $645K
Jun 28, 2024 Jul 2, 2024 Wilson Marc CFO Sell 10.0 -32,129 -22.43% ✓ $1.4M
Jun 26, 2024 Jun 28, 2024 Knight Jeff E. COO Sell 48.8 -956 -1.79% ✓ $42.4K
Jun 25, 2024 Jun 26, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.59% ✓ $136.1K
Jun 24, 2024 Jun 25, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 20.0 -9,500 -25.48% ✗ $434.4K
Jun 21, 2024 Jun 24, 2024 Hassard James Chief Commercial Officer Sell 7.5 -15,000 -33.89% ✓ $669.9K
Jun 10, 2024 Jun 11, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.46% ✓ $131.6K
Jun 7, 2024 Jun 11, 2024 Deardorf Caren Director Neutral 90.0 +3,400 56.67% ✗ -
Jun 7, 2024 Jun 11, 2024 Vivaldi Coelho Rogerio Director Neutral 90.0 +3,400 30.91% ✗ -
Jun 7, 2024 Jun 11, 2024 Okey Stephanie Director Neutral 90.0 +3,400 56.67% ✗ -
Jun 7, 2024 Jun 11, 2024 Nichols Weston Director Neutral 90.0 +3,400 56.67% ✗ -
Jun 7, 2024 Jun 11, 2024 Fust Matthew K Director Neutral 90.0 +3,400 18.34% ✗ -
Jun 7, 2024 Jun 11, 2024 Bedrosian Camille L Director Neutral 90.0 +3,400 56.67% ✗ -
Jun 7, 2024 Jun 11, 2024 WIERENGA WENDALL Director Neutral 82.5 +3,400 3.21% ✗ -
May 28, 2024 May 30, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.35% ✓ $142.5K
May 10, 2024 May 14, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.24% ✓ $148.3K
May 8, 2024 May 10, 2024 Struthers Richard Scott CEO Sell 22.5 -107,448 -8.48% ✓ $5.3M
Apr 18, 2024 Apr 22, 2024 Struthers Richard Scott CEO Neutral 52.5 -350 -0.03% ✗ -
Apr 15, 2024 Apr 17, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -14,375 -34.10% ✓ $639.3K
Apr 15, 2024 Apr 17, 2024 Struthers Richard Scott CEO Neutral 52.5 - 0.00% ✗ -
Apr 4, 2024 Apr 8, 2024 Struthers Richard Scott CEO Sell 32.5 -40,951 -3.47% ✓ $2M
Mar 28, 2024 Apr 2, 2024 Okey Stephanie Director Sell 20.0 -17,500 -74.47% ✗ $811.7K
Mar 22, 2024 Mar 26, 2024 Knight Jeff E. COO Sell 17.5 -32,359 -38.10% ✗ $1.4M
Mar 20, 2024 Mar 22, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 20.0 -15,089 -15.11% ✗ $664.8K
Mar 20, 2024 Mar 22, 2024 Fust Matthew K Director Sell 5.0 -60,000 -44.73% ✓ $2.6M
Mar 18, 2024 Mar 20, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 48.8 -411 -1.42% ✓ $15.7K
Mar 18, 2024 Mar 20, 2024 Knight Jeff E. COO Sell 32.5 -4,283 -7.23% ✓ $163.4K
Mar 18, 2024 Mar 20, 2024 Hassard James Chief Commercial Officer Sell 32.5 -1,741 -5.62% ✓ $66.4K
Mar 18, 2024 Mar 20, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,655 -3.80% ✓ $139.4K
Mar 18, 2024 Mar 20, 2024 Wilson Marc CFO Sell 26.3 -10,925 -8.99% ✓ $449.8K
Mar 18, 2024 Mar 20, 2024 Struthers Richard Scott CEO Sell 42.5 -12,687 -1.10% ✓ $483.9K
Mar 4, 2024 Mar 6, 2024 Hassard James Chief Commercial Officer Neutral 90.0 +17,000 121.43% ✗ -
Mar 4, 2024 Mar 6, 2024 Wilson Marc CFO Neutral 90.0 +25,500 26.55% ✗ -
Mar 4, 2024 Mar 6, 2024 Struthers Richard Scott CEO Neutral 85.0 +65,000 5.98% ✗ -
Mar 4, 2024 Mar 6, 2024 Pizzuti Dana Chief Med and Dev Officer Neutral 90.0 +23,000 389.11% ✗ -
Mar 4, 2024 Mar 6, 2024 Knight Jeff E. COO Neutral 90.0 +23,000 63.50% ✗ -
Mar 4, 2024 Mar 6, 2024 Betz Stephen F. Chief Scientific Officer Neutral 90.0 +23,000 31.38% ✗ -
Feb 12, 2024 Feb 14, 2024 Struthers Richard Scott CEO Neutral 52.5 - 0.00% ✗ -
May 22, 2023 Feb 12, 2024 Knight Jeff E. COO Buy 86.3 +1,822 5.30% ✗ $27.3K
Jan 25, 2024 Jan 26, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.93% ✓ $111.8K
Jan 10, 2024 Jan 12, 2024 Betz Stephen F. Chief Scientific Officer Sell 37.5 -3,000 -3.78% ✓ $113K
Jan 3, 2024 Jan 4, 2024 Pizzuti Dana Chief Med and Dev Officer Sell 7.5 -14,375 -70.86% ✓ $503.1K